Literature DB >> 1954402

Neonatal sympathetic denervation alters the development of in vitro spleen cell proliferation and differentiation.

K D Ackerman1, K S Madden, S Livnat, S Y Felten, D L Felten.   

Abstract

The ontogeny of spleen cell proliferation to T and B cell mitogens and immunoglobulin secretion, measured in vitro, was examined in neonatally sympathectomized Fischer 344 (F344) rats, administered the neurotoxic drug 6-hydroxydopamine (6-OHDA) from 1 to 3 days of age. Compared to cells from age-matched controls, spleen cells from neonatally sympathectomized animals, aged 7-14 days, exhibited a shift in the proliferative response to the T cell mitogen, concanavalin A (Con A), with reduced proliferation in the presence of low doses of Con A, but increased proliferation with higher doses. During the same period, from 7 to 14 days, the B cell mitogen STM/DxS inhibited proliferation by spleen cells from all rats, and no effect of sympathectomy was observed. As adult-like patterns of mitogen responsiveness emerged from 21 to 42 days of age, neonatally sympathectomized rats showed reduced proliferative responses of both T and B cells. This effect dissipated by 56 days of age. Polyclonal immunoglobulin (Ig) production by B cells was assessed in vitro in the presence or absence of STM/DxS. Neonatal sympathectomy resulted in reduced spontaneous IgM production throughout development. From 28 to 42 days of age, when mitogen-triggered IgM secretion first developed, neonatal sympathectomy decreased the magnitude of the response. By 56 days of age, mitogen-induced IgM secretion was no longer affected by sympathectomy, similar to the proliferative response. Gender influenced the time course of sympathectomy-induced changes in spleen cell proliferation and differentiation; however, the magnitude and direction of these changes were similar in both males and females. Desipramine, administered prior to 6-OHDA, prevented both sympathetic denervation and the 6-OHDA-induced changes in spleen cell responsiveness. This indicates that the alterations in immune function were dependent on NA nerve fiber destruction and were not simply the result of direct 6-OHDA action on other cells. The results of this study suggest that sympathetic innervation may play an important potentiating role in the development of the lymphoid system, through effects on lymphocyte proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954402     DOI: 10.1016/0889-1591(91)90021-2

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  6 in total

Review 1.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

Review 2.  Harmful molecular mechanisms in sepsis.

Authors:  Daniel Rittirsch; Michael A Flierl; Peter A Ward
Journal:  Nat Rev Immunol       Date:  2008-10       Impact factor: 53.106

3.  IL-4 Is Required for Sex Differences in Vulnerability to Focal Ischemia in Mice.

Authors:  Xiaoxing Xiong; Lijun Xu; Liang Wei; Robin E White; Yi-Bing Ouyang; Rona G Giffard
Journal:  Stroke       Date:  2015-06-30       Impact factor: 7.914

4.  Norepinephrine modulates myelopoiesis after experimental thermal injury with sepsis.

Authors:  Y Tang; R Shankar; M Gamboa; S Desai; R L Gamelli; S B Jones
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

5.  Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response.

Authors:  Michael A Flierl; Daniel Rittirsch; Brian A Nadeau; J Vidya Sarma; Danielle E Day; Alex B Lentsch; Markus S Huber-Lang; Peter A Ward
Journal:  PLoS One       Date:  2009-02-12       Impact factor: 3.240

Review 6.  Autonomic nervous system and immune system interactions.

Authors:  M J Kenney; C K Ganta
Journal:  Compr Physiol       Date:  2014-07       Impact factor: 9.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.